Lafutinin Tablet (Lafutidine)

Adult dose

1. Short-term treatment of gastric ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. Clinical studies with treatment for up to 8 weeks showed healing in most patients within 8 weeks, although the healing period may occasionally vary by patient. 2. Short-term treatment of duodenal ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. Clinical studies with treatment for up to 6 weeks showed healing in most patients within 6 weeks, although the healing period may occasionally vary by patient. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose is 10mg of lafutidine orally once daily before bedtime. Clinical studies with treatment for up to 2 weeks showed healing in most patients within 2 weeks, although the healing period may occasionally vary by patient. 4. Combination antibiotic therapy in patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication before anesthesia: The usual dose is 10mg of lafutidine per administration, given twice orally (before bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer 10mg of lafutidine orally twice daily.

This medication should not be used by patients who are allergic to any of its ingredients. It also contains lactose, so patients with a genetic condition affecting lactose breakdown should not take this medication. Those allergic to soybean oil, soy, or peanuts should also avoid this medication. Patients with a history of drug allergies, or those with liver or kidney dysfunction, patients undergoing dialysis, and elderly individuals should be cautious when using this medication. Patients with abnormalities in fat metabolism or those taking lipid-lowering medications should also be administered with caution. This medication may rarely cause severe allergic reactions, liver dysfunction, or blood cell reductions, so if any symptoms occur, the medication should be discontinued immediately, and medical consultation should be sought. Additionally, various side effects such as gastrointestinal symptoms, headache, dizziness, and rash have been reported, so careful monitoring is necessary. If symptoms suggesting malignancy or suspected gastric cancer are present, testing should be completed before taking this medication, following the physician's instructions. During treatment, regular blood tests and liver and kidney function tests should be performed to check for any abnormalities. Particularly, patients at risk of fat overload should check their blood lipid levels and adjust the dosage if necessary. Elderly patients may have reduced physical function, so special care should be taken regarding the dosage and administration interval. Patients undergoing dialysis may have elevated blood drug concentrations, so treatment should begin at a low dose and be administered with caution. Pregnant or breastfeeding women should only use this medication if necessary, as it may affect the fetus or newborn, based on the physician's judgment. Safety in children has not been established, so it should be administered cautiously to pediatric patients. This medication should be kept out of reach of children and stored in its original container to prevent misuse or quality degradation.

• Shock
• anaphylactic symptoms
• pallor
• hypotension
• generalized rash
• dyspnea
• hepatic dysfunction
• jaundice
• agranulocytosis
• pharyngitis

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle